Members |
conceptInactivationValue |
^91m^Yttrium |
Nonconformance to editorial policy component |
^91m^Yttrium (substance) |
Nonconformance to editorial policy component |
^92^Strontium |
Nonconformance to editorial policy component |
^92^Strontium (substance) |
Nonconformance to editorial policy component |
^92^Yttrium |
Nonconformance to editorial policy component |
^92^Yttrium (substance) |
Nonconformance to editorial policy component |
^93^Molybdenum |
Nonconformance to editorial policy component |
^93^Molybdenum (substance) |
Nonconformance to editorial policy component |
^93^Technetium |
Nonconformance to editorial policy component |
^93^Technetium (substance) |
Nonconformance to editorial policy component |
^93^Yttrium |
Nonconformance to editorial policy component |
^93^Yttrium (substance) |
Nonconformance to editorial policy component |
^93^Zirconium |
Nonconformance to editorial policy component |
^93^Zirconium (substance) |
Nonconformance to editorial policy component |
^93m^Molybdenum |
Nonconformance to editorial policy component |
^93m^Molybdenum (substance) |
Nonconformance to editorial policy component |
^94m^Technetium |
Nonconformance to editorial policy component |
^94m^Technetium (substance) |
Nonconformance to editorial policy component |
^95^Ruthenium |
Nonconformance to editorial policy component |
^95^Ruthenium (substance) |
Nonconformance to editorial policy component |
^95^Technetium |
Nonconformance to editorial policy component |
^95^Technetium (substance) |
Nonconformance to editorial policy component |
^95^Zirconium |
Nonconformance to editorial policy component |
^95^Zirconium (substance) |
Nonconformance to editorial policy component |
^95m^Technetium |
Nonconformance to editorial policy component |
^95m^Technetium (substance) |
Nonconformance to editorial policy component |
^96^Technetium |
Nonconformance to editorial policy component |
^96^Technetium (substance) |
Nonconformance to editorial policy component |
^97^Ruthenium |
Nonconformance to editorial policy component |
^97^Ruthenium (substance) |
Nonconformance to editorial policy component |
^97^Technetium |
Nonconformance to editorial policy component |
^97^Technetium (substance) |
Nonconformance to editorial policy component |
^97^Zirconium |
Nonconformance to editorial policy component |
^97^Zirconium (substance) |
Nonconformance to editorial policy component |
^97m^Technetium |
Nonconformance to editorial policy component |
^97m^Technetium (substance) |
Nonconformance to editorial policy component |
^98^Technetium |
Nonconformance to editorial policy component |
^98^Technetium (substance) |
Nonconformance to editorial policy component |
^99^Molybdenum |
Nonconformance to editorial policy component |
^99^Molybdenum (substance) |
Nonconformance to editorial policy component |
^99^Rhodium |
Nonconformance to editorial policy component |
^99^Rhodium (substance) |
Nonconformance to editorial policy component |
^99^Technetium |
Nonconformance to editorial policy component |
^99^Technetium (substance) |
Nonconformance to editorial policy component |
^99m^Rhodium |
Nonconformance to editorial policy component |
^99m^Rhodium (substance) |
Nonconformance to editorial policy component |
^99m^Technetium |
Nonconformance to editorial policy component |
^99m^Technetium (substance) |
Nonconformance to editorial policy component |
a |
Concept non-current |
a (tumor staging) |
Concept non-current |
a - At autopsy |
Concept non-current |
a - At autopsy (tumor staging) |
Concept non-current |
a-Methyfentanyl |
Concept non-current |
a.m. peak specimen |
Concept non-current |
a.m. peak specimen (specimen) |
Concept non-current |
abatacept 125 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) |
Outdated |
abatacept 125 mg / 1 mL injection, 4 x 1 mL injection devices (medicinal product pack) |
Outdated |
abatacept 125 mg/mL injection, 4 x 1 mL injection devices |
Outdated |
abatacept 125 mg/mL injection, injection device |
Outdated |
acute canine polyradiculoneuropathy |
Concept non-current |
acute myocardial infarction of posterolateral wall (disorder) |
Concept non-current |
adalimumab 40 mg / 0.4 mL injection, 0.4 mL injection device (medicinal product unit of use) |
Outdated |
adalimumab 40 mg / 0.4 mL injection, 2 x 0.4 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.4 mL injection, 4 x 0.4 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.4 mL injection, 6 x 0.4 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 0.8 mL injection device (medicinal product unit of use) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 1 x 0.8 mL injection device (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 2 x 0.8 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 3 x 0.8 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 4 x 0.8 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg / 0.8 mL injection, 6 x 0.8 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL injection devices |
Outdated |
adalimumab 40 mg/0.4 mL injection, 4 x 0.4 mL injection devices |
Outdated |
adalimumab 40 mg/0.4 mL injection, 6 x 0.4 mL injection devices |
Outdated |
adalimumab 40 mg/0.4 mL injection, injection device |
Outdated |
adalimumab 40 mg/0.8 mL injection, 0.8 mL injection device |
Outdated |
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL injection devices |
Outdated |
adalimumab 40 mg/0.8 mL injection, 3 x 0.8 mL injection devices |
Outdated |
adalimumab 40 mg/0.8 mL injection, 4 x 0.8 mL injection devices |
Outdated |
adalimumab 40 mg/0.8 mL injection, 6 x 0.8 mL injection devices |
Outdated |
adalimumab 40 mg/0.8 mL injection, injection device |
Outdated |
adalimumab 80 mg / 0.8 mL injection, 0.8 mL injection device (medicinal product unit of use) |
Outdated |
adalimumab 80 mg / 0.8 mL injection, 1 x 0.8 mL injection device (medicinal product pack) |
Outdated |
adalimumab 80 mg / 0.8 mL injection, 3 x 0.8 mL injection devices (medicinal product pack) |
Outdated |
adalimumab 80 mg/0.8 mL injection, 0.8 mL injection device |
Outdated |
adalimumab 80 mg/0.8 mL injection, 3 x 0.8 mL injection devices |
Outdated |
adalimumab 80 mg/0.8 mL injection, injection device |
Outdated |
additional |
Outdated |
additional (characteristic type) |
Outdated |
adrenaline (epinephrine) 150 microgram/0.15 mL injection, 0.15 mL injection device |
Outdated |
adrenaline (epinephrine) 150 microgram/0.15 mL injection, injection device |
Outdated |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 0.3 mL injection device |
Outdated |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, 2 x 0.3 mL injection devices |
Outdated |
adrenaline (epinephrine) 150 microgram/0.3 mL injection, injection device |
Outdated |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 0.3 mL injection device |
Outdated |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, 2 x 0.3 mL injection devices |
Outdated |
adrenaline (epinephrine) 300 microgram/0.3 mL injection, injection device |
Outdated |
adrenaline (epinephrine) 500 microgram/0.3 mL injection, 0.3 mL injection device |
Outdated |
adrenaline (epinephrine) 500 microgram/0.3 mL injection, injection device |
Outdated |
alirocumab 150 mg / 1 mL injection, 1 mL injection device (medicinal product unit of use) |
Outdated |
alirocumab 150 mg / 1 mL injection, 1 x 1 mL injection device (medicinal product pack) |
Outdated |